Sandbox 55: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
==HMG-CoA Reductase== | ==HMG-CoA Reductase== | ||
<applet load='1hwk' size='400' frame='true' align='right' caption='HMG-CoA Reductase in complex with Lipitor' /> | <applet load='1hwk' size='400' frame='true' align='right' caption='HMG-CoA Reductase in complex with Lipitor' /> | ||
===Mechanism of Action=== | |||
[[Image:Statin_mechanism.gif]] | |||
HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate in the cholesterol biosynthesis pathway. Atorvastatin selectively and competitively inhibits HMG-CoA reductase. The inhibition subsequently increases the expression of LDL receptors on hepatocytes, which increases LDL uptake by hepatocytes, therefore decreasing the LDL-cholesterol concentration in the blood. Atorvastatin also increases levels of HDL-cholesterol.<ref>LDL-C, Decreasing. "DrugBank: Atorvastatin (DB01076)." DrugBank: Welcome. Web. 09 Mar. 2011. <http://www.drugbank.ca/drugs/DB01076>.</ref> | |||
=== | |||
===Active Site=== | |||
